by Kristina Slavova | Feb 7, 2019 | All News, Research and Clinical Trials
The Neuroendocrine Tumor Research Foundation (NETRF) continues its aggressive funding of neuroendocrine tumor (NET) research with eight new grants totaling $2.5 million. With this newest round of funding, NETRF expands its portfolio to include research into lung NETs,...
by Kristina Slavova | Feb 1, 2019 | All News, Awareness and Information
#WorldCancerDay is on February 4, and this year INCA is joining the campaign by highlighting three key needs of NET patients: greater awareness about NETs among physicians, equity in best treatment everywhere and more research in NETs with patients involved. INCA is...
by Kristina Slavova | Jan 28, 2019 | All News, INCA
For the first time Presidents of each neuroendocrine society around the globe were invited to join together at a meeting in Palma de Mallorca, Spain to discuss key topics from a global perspective. The first NET Leadership Workshop included representatives from: Asia...
by Kristina Slavova | Jan 25, 2019 | All News, Awareness and Information
Kathleen Vandenborne is the first NET specialist nurse of the University Hospital of Antwerp (UZA), one of the two Center of Excellence in Belgium. This is fantastic news for NET patients in greater Antwerp. Although specialized nurses are not yet official in Belgium,...
by Kristina Slavova | Jan 18, 2019 | All News, Research and Clinical Trials
Five scientists helping Neuroendocrine Tumor Research Foundation (NETRF) advance treatments of neuroendocrine tumors (NETs) have been named among the most influential in the world for 2018. Clarivate Analytics identifies the most influential researchers by the number...
by Kristina Slavova | Jan 17, 2019 | All News, INCA
As member of WECAN, the Workgroup of European Cancer patient Advocacy Networks, INCA was invited to discuss the objectives and format of the WECAN Academy, a new educational program for the cancer patient community. The WECAN Academy Program Committee Meeting took...
